{"id":"timolol-vehicle-placebo","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Timolol Vehicle is the inactive carrier solution used in ophthalmic formulations of timolol, designed to match the physical and chemical properties of the active drug product without containing the beta-blocker itself. It serves as a control comparator in clinical trials to isolate the therapeutic effects of timolol from vehicle-related effects.","oneSentence":"This is a placebo vehicle formulation with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:38:47.713Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control in clinical trials for glaucoma and ocular hypertension"}]},"trialDetails":[{"nctId":"NCT02250651","phase":"PHASE3","title":"Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-12-15","conditions":"Glaucoma, Open-Angle, Ocular Hypertension","enrollment":528},{"nctId":"NCT02247804","phase":"PHASE3","title":"Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-12-15","conditions":"Glaucoma, Open-Angle, Ocular Hypertension","enrollment":594},{"nctId":"NCT02730871","phase":"PHASE4","title":"Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®","status":"TERMINATED","sponsor":"Alcon Research","startDate":"2016-06-24","conditions":"Open-angle Glaucoma, Ocular Hypertension","enrollment":173},{"nctId":"NCT02312544","phase":"PHASE2","title":"Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Ocular Therapeutix, Inc.","startDate":"2014-11","conditions":"Glaucoma, Ocular Hypertension","enrollment":72},{"nctId":"NCT00759239","phase":"PHASE4","title":"Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2008-09","conditions":"Open-angle Glaucoma, Ocular Hypertension","enrollment":36},{"nctId":"NCT01215786","phase":"PHASE1","title":"Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma","status":"COMPLETED","sponsor":"Allergan","startDate":"2010-10","conditions":"Glaucoma, Open-Angle, Ocular Hypertension","enrollment":50},{"nctId":"NCT01520116","phase":"PHASE1, PHASE2","title":"Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension","status":"UNKNOWN","sponsor":"Altheos, Inc.","startDate":"2012-01","conditions":"Primary Open Angle Glaucoma, Ocular Hypertension","enrollment":180},{"nctId":"NCT00471068","phase":"PHASE4","title":"Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension","status":"TERMINATED","sponsor":"Alcon Research","startDate":"2007-03","conditions":"Open-angle Glaucoma, Ocular Hypertension","enrollment":46},{"nctId":"NCT00815373","phase":"NA","title":"The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG)","status":"WITHDRAWN","sponsor":"Meir Medical Center","startDate":"2008-12","conditions":"Open-Angle Glaucoma, Ocular Hypertension","enrollment":""},{"nctId":"NCT00293800","phase":"PHASE3","title":"A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2004-07","conditions":"Open-Angle Glaucoma, Ocular Hypertension","enrollment":173},{"nctId":"NCT00293787","phase":"PHASE3","title":"A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2004-06","conditions":"Open-angle Glaucoma, Ocular Hypertension","enrollment":156}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Timolol Vehicle (placebo)","genericName":"Timolol Vehicle (placebo)","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo vehicle formulation with no active pharmacological mechanism. Used for Placebo control in clinical trials for glaucoma and ocular hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}